Blue Cross Idaho Medical Policy Updates – April 2021

Click here to view the Blue Cross Idaho Medical Policy Updates »

 April 2021 Blue Cross Idaho Medical Policy Updates:

• Cognitive Rehabilitation
• Computer-Assisted Navigation for Orthopedic Procedure
• Cost Effective Medical Drugs
• Cost Effective Medical Drugs
• Endothelial Keratoplasty
• Erythropoiesis-Stimulating Agents
• Functional Neuromuscular Electrical Stimulation
• Genetic Testing for Facioscapulohumeral Muscular Dystrophy
• Genetic Testing for Heterozygous Familial Hypercholesterolemia
• Genetic Testing for Macular Degeneration
• Implantation of Intrastromal Corneal Ring Segments
• Intravitreal and Punctum Corticosteroid Implants
• New and Emerging Technology
• Ophthalmologic Techniques That Evaluate the Posterior Segment for Glaucoma
• Ophthalmologic Techniques That Evaluate the Posterior Segment for Glaucoma
• Optical Coherence Tomography of the Anterior Eye Segment
• Outpatient Pulmonary Rehabilitation
• PDF: 07.01.163_10-22-20.pdf
• Photodynamic Therapy for Choroidal Neovascularization
• Progesterone Therapy as a Technique to Reduce Preterm Birth in High-Risk Pregnancies
• Reproductive Techniques
• Testing for the Detection of SARS-CoV-2 or the Diagnosis of Coronavirus Disease 2019
• Treatment for Duchenne Muscular Dystrophy
• Ultrasonographic Measurement of Carotid Intima-Medial Thickness as an Assessment of Subclinical Atherosclerosis
• Whole Exome and Whole Genome Sequencing for Diagnosis of Genetic Disorders

Added 5/25/2021;

• Amniotic Membrane and Amniotic Fluid
• Bariatric Surgery
• Chimeric Antigen Receptor (CAR-T) Therapy for Hematologic Malignancies
• Chimeric Antigen Receptor (CAR-T) Therapy for Leukemia and Lymphoma
• Complement Inhibitors: Eculizumab (Soliris) and Ravulizumab (Ultomiris)
• Dry Needling of Trigger Points for Myofascial Pain
• Experimental / Investigational Services
• General Coverage Guidelines
• Genetic Testing for Marfan Syndrome, Thoracic Aortic Aneurysms and Dissections, and Related
• Germline Genetic Testing for Pancreatic Cancer Susceptibility Genes
• Interventions for Progressive Scoliosis
• Letermovir (Prevymis) for Cytomegalovirus Prophylaxis in Hematopoietic Stem Cell Transplant
• Oversight of Third-Party Entities
• Pharmacologic Compounds
• Provider Administered Drugs  –Site of Care Guidelines
• Specialty Drugs
• Stretching Devices for the Treatment of Joint Stiffness and Contracture
• Telehealth Virtual Care Services
• Temporomandibular Joint Disorder
• Tepezza (teprotumumab-trbw)
• Treatment for Duchenne Muscular Dystrophy
• Trigger Point and Tender Point Injections
• Vertebral Axial Decompression

Click here to view the Blue Cross Idaho Medical Policy Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.